Patent details

EP1811986 Title: GABAPENTIN PRODRUG SUSTAINED RELEASE ORAL DOSAGE FORMS

Basic Information

Publication number:
EP1811986
PCT Application Number:
PCT/US/2005/040127
Type:
European Patent Granted for LU
Legal Status:
Lapsed
Application number:
EP058262007
PCT Publication Number:
WO/2006/050514
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
GABAPENTIN PRODRUG SUSTAINED RELEASE ORAL DOSAGE FORMS
French Title of Invention:
FORMES POSOLOGIQUES ORALES A LIBERATION PROLONGEE D'UN PROMEDICAMENT DE LA GABAPENTINE
German Title of Invention:
ORALE DARREICHUNGSFORMEN VON GABAPENTIN-PRODRUG MIT VERZÖGERTER FREISETZUNG
SPC Number:

Dates

Filing date:
03/11/2005
Grant date:
26/03/2014
EP Publication Date:
26/03/2014
PCT Publication Date:
11/05/2006
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
01/08/2007
EP B1 Publication Date:
26/03/2014
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
03/11/2014
Expiration date:
03/11/2025
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
03/11/2005
 
 

Name:
XenoPort Inc.
Address:
3410 Central Expressway, Santa Clara, CA 95051, United States (US)

Inventor

1

Name:
LEUNG Manshiu
Address:
United States (US)

2

Name:
CUNDY Kenneth, C.
Address:
United States (US)

3

Name:
STACH Paul, E.
Address:
United States (US)

4

Name:
SASTRY Srikonda
Address:
United States (US)

5

Name:
KADRI Balaji, V.
Address:
United States (US)

Priority

Priority Number:
625737 P
Priority Date:
04/11/2004
Priority Country:
United States (US)

Classification

Main IPC Class:
A61K 31/225;
Filing date Document type Number of pages